Growth Accelerated by Adoption of Molecular Cytogenetics in Genetic Disorder Diagnosis
Molecular cytogenetics involves techniques like fluorescence in situ hybridization (FISH), flow cytometry, and chromosome microarray analysis (CMA) that are used for the visualization and analysis of genomes. With the help of specific molecular probes, these techniques allow researchers to better identify chromosome abnormalities related to genetic disorders. The growing prevalence of genetic diseases and rising awareness about molecular diagnostics is propelling the demand for molecular cytogenetics solutions. Molecular cytogenetics play a vital role in diagnosing rare hematological malignancies, genetic diseases and various forms of cancers accurately.
The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 Mn in 2023 and is expected to exhibit a CAGR of 24.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising adoption of molecular cytogenetics assays and techniques in genetic disorder diagnosis is a key trend fueling the market growth. Molecular cytogenetics offer highly accurate and reliable results along with the ability to detect even the smallest of genetic mutations. This has increased its adoption over traditional cytogenetic methods. Further, the development of advanced molecular probes and automation of molecular cytogenetic workflows is boosting efficiency and reducing diagnosis costs. This widening applicability and improvements in technology are expected to drive increased demand over the forecast period.
Segment Analysis
The global Molecular Cytogenetics market is segmented based on technology, product, application, end-user, and region. The fluorescence in situ hybridization (FISH) segment dominates the technology segment of the global market. FISH is a powerful technique that can detect abnormalities at the chromosome and gene level with high sensitivity and specificity. FISH has become a routine diagnostic test for many different types of cancer and genetic conditions.
Key Takeaways
The global Molecular Cytogenetics Market Demand is expected to witness high growth during the forecast period of 2023 to 2030. The market size for 2023 is US$ 4,211.4 Mn.
Regional analysis
North America dominates the regional segment of the global Molecular Cytogenetics market and is expected to continue its dominance during the forecast period. This is attributed to the rising incidences of cancer and genetic disorders, increasing adoption of advanced molecular cytogenetics techniques for diagnosis in clinical research, and growing investments by government and private organizations to support research activities in the region.
Key players operating in the Molecular Cytogenetics market are Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., Applied Spectral Imaging, Inc., BI Biological Industries, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., CytoTest Inc., Cytognomix, Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Bionano Genomics, Inc., Precipio, Inc., and Leica Biosystems.
Get more insights on this topic: http://marketerefforts.weebly.com/home/molecular-cytogenetics-is-estimated-to-witness-high-growth-owing-to-increasing-incidence-of-genetic-disorders
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian